Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.
Cell Death Differ
Springer Science and Business Media LLC
MetadataShow full item record
Velletri, T., Huang, Y., Wang, Y., Li, Q., Hu, M., Xie, N., Yang, Q., et al. (2021). Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.. Cell Death Differ, 28 (1), 156-169. https://doi.org/10.1038/s41418-020-0590-4
p53 plays a pivotal role in controlling the differentiation of mesenchymal stem cells (MSCs) by regulating genes involved in cell cycle and early steps of differentiation process. In the context of osteogenic differentiation of MSCs and bone homeostasis, the osteoprotegerin/receptor activator of NF-κB ligand/receptor activator of NF-κB (OPG/RANKL/RANK) axis is a critical signaling pathway. The absence or loss of function of p53 has been implicated in aberrant osteogenic differentiation of MSCs that results in higher bone formation versus erosion, leading to an unbalanced bone remodeling. Here, we show by microCT that mice with p53 deletion systemically or specifically in mesenchymal cells possess significantly higher bone density than their respective littermate controls. There is a negative correlation between p53 and OPG both in vivo by analysis of serum from p53+/+, p53+/-, and p53-/- mice and in vitro by p53 knockdown and ChIP assay in MSCs. Notably, high expression of Opg or its combination with low level of p53 are prominent features in clinical cancer lesion of osteosarcoma and prostate cancer respectively, which correlate with poor survival. Intra-bone marrow injection of prostate cancer cells, together with androgen can suppress p53 expression and enhance local Opg expression, leading to an enhancement of bone density. Our results support the notion that MSCs, as osteoblast progenitor cells and one major component of bone microenvironment, represent a cellular source of OPG, whose amount is regulated by the p53 status. It also highlights a key role for the p53-OPG axis in regulating the cancer associated bone remodeling.
Animals, Bone Remodeling, Cell Differentiation, Cell Line, Tumor, Humans, Male, Mesenchymal Stem Cells, Mice, Mice, Inbred C57BL, Mice, Nude, NF-kappa B, Osteogenesis, Osteoprotegerin, Osteosarcoma, Prostatic Neoplasms, Receptor Activator of Nuclear Factor-kappa B, Signal Transduction, Transcription Factor RelA, Tumor Suppressor Protein p53
Ministry of Science and Technology of the People’s Republic of China (Chinese Ministry of Science and Technology) (2018YFA0107500, 2018YFC1704300)
National Natural Science Foundation of China (National Science Foundation of China) (81861138015, 31961133024, 31771641, 31601106, 81930085 and 81571612, 31601106)
External DOI: https://doi.org/10.1038/s41418-020-0590-4
This record's URL: https://www.repository.cam.ac.uk/handle/1810/330142
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org